Cargando…

Does supplier concentration matter to investors during the COVID-19 crisis: evidence from China?

The literature shows that investor attention to customer–supplier disclosure increases when suppliers’ information arrival is anticipated. Due to the widespread of city lockdowns in China and the implementation of social distancing to control the COVID-19 pandemic, investor attention to potential di...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Louis T. W., Poon, Jack S. C., Tang, Shaolong, Wang, Jacqueline Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510340/
https://www.ncbi.nlm.nih.gov/pubmed/36189117
http://dx.doi.org/10.1186/s40854-022-00391-0
_version_ 1784797420963495936
author Cheng, Louis T. W.
Poon, Jack S. C.
Tang, Shaolong
Wang, Jacqueline Wenjie
author_facet Cheng, Louis T. W.
Poon, Jack S. C.
Tang, Shaolong
Wang, Jacqueline Wenjie
author_sort Cheng, Louis T. W.
collection PubMed
description The literature shows that investor attention to customer–supplier disclosure increases when suppliers’ information arrival is anticipated. Due to the widespread of city lockdowns in China and the implementation of social distancing to control the COVID-19 pandemic, investor attention to potential disruption of the supply chain spikes, leading to a price devaluation for firms with high supplier concentration risk. We find that a higher degree of supplier concentration is related to more serious stock price declines over the short-term and medium-term windows right after the Wuhan lockdown. This result lends support to the argument that the concentration risk of suppliers is a significant consideration for China stock market investors, especially under the potential financial distress at the firm level induced by the COVID-19 crisis.
format Online
Article
Text
id pubmed-9510340
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95103402022-09-26 Does supplier concentration matter to investors during the COVID-19 crisis: evidence from China? Cheng, Louis T. W. Poon, Jack S. C. Tang, Shaolong Wang, Jacqueline Wenjie Financ Innov Research The literature shows that investor attention to customer–supplier disclosure increases when suppliers’ information arrival is anticipated. Due to the widespread of city lockdowns in China and the implementation of social distancing to control the COVID-19 pandemic, investor attention to potential disruption of the supply chain spikes, leading to a price devaluation for firms with high supplier concentration risk. We find that a higher degree of supplier concentration is related to more serious stock price declines over the short-term and medium-term windows right after the Wuhan lockdown. This result lends support to the argument that the concentration risk of suppliers is a significant consideration for China stock market investors, especially under the potential financial distress at the firm level induced by the COVID-19 crisis. Springer Berlin Heidelberg 2022-09-26 2022 /pmc/articles/PMC9510340/ /pubmed/36189117 http://dx.doi.org/10.1186/s40854-022-00391-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Cheng, Louis T. W.
Poon, Jack S. C.
Tang, Shaolong
Wang, Jacqueline Wenjie
Does supplier concentration matter to investors during the COVID-19 crisis: evidence from China?
title Does supplier concentration matter to investors during the COVID-19 crisis: evidence from China?
title_full Does supplier concentration matter to investors during the COVID-19 crisis: evidence from China?
title_fullStr Does supplier concentration matter to investors during the COVID-19 crisis: evidence from China?
title_full_unstemmed Does supplier concentration matter to investors during the COVID-19 crisis: evidence from China?
title_short Does supplier concentration matter to investors during the COVID-19 crisis: evidence from China?
title_sort does supplier concentration matter to investors during the covid-19 crisis: evidence from china?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510340/
https://www.ncbi.nlm.nih.gov/pubmed/36189117
http://dx.doi.org/10.1186/s40854-022-00391-0
work_keys_str_mv AT chenglouistw doessupplierconcentrationmattertoinvestorsduringthecovid19crisisevidencefromchina
AT poonjacksc doessupplierconcentrationmattertoinvestorsduringthecovid19crisisevidencefromchina
AT tangshaolong doessupplierconcentrationmattertoinvestorsduringthecovid19crisisevidencefromchina
AT wangjacquelinewenjie doessupplierconcentrationmattertoinvestorsduringthecovid19crisisevidencefromchina